$CNO
CNO Financial Group, Inc. Stock $cno

$cno Overview Financials Valuation SEC Filings Company Website

2017 Q1 Form 10-Q Financial Statement

#000122460817000024 Filed on May 03, 2017

Income Statement

Concept	2017 Q1	2016 Q1
Revenue	$1.071B	$960.4M
YoY Change	11.48%	-1.83%
Cost Of Revenue	$669.3M	$619.0M
YoY Change	8.13%	2.15%
Gross Profit	$401.4M	$341.4M
YoY Change	17.57%	-8.3%
Gross Profit Margin	37.49%	35.55%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$70.00M	$68.20M
YoY Change	2.64%	-3.94%
% of Gross Profit	17.44%	19.98%
Operating Expenses	$943.2M	$892.2M
YoY Change	5.72%	2.02%
Operating Profit	-$541.8M	-$550.8M
YoY Change	-1.63%	9.68%
Interest Expense	$30.80M	$27.70M
YoY Change	11.19%	28.84%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$96.70M	$40.50M
YoY Change	138.77%	-50.79%
Income Tax	$34.40M	-$5.000M
% Of Pretax Income	35.57%	-12.35%
Net Earnings	$62.30M	$45.50M
YoY Change	36.92%	-13.83%
Net Earnings / Revenue	5.82%	4.74%
Basic Earnings Per Share	$0.36	$0.25
Diluted Earnings Per Share	$0.36	$0.25
COMMON SHARES
Basic Shares Outstanding	173.4M shares	180.4M shares
Diluted Shares Outstanding	175.1M shares	182.1M shares

Balance Sheet

Concept	2017 Q1	2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$884.7M	$635.7M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$26.39B	$24.94B
YoY Change	5.82%	-2.21%
Other Assets	$698.0M	$829.0M
YoY Change	-15.8%	23.73%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$31.98B	$31.46B
YoY Change	1.65%	-0.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt	$4.195B	$4.116B
YoY Change	1.92%	9.61%
Other Long-Term Liabilities	$798.0M	$789.0M
YoY Change	1.14%	18.29%
Total Long-Term Liabilities	$4.993B	$4.905B
YoY Change	1.79%	10.92%
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities	$4.993B	$4.905B
Total Liabilities	$27.82B	$27.23B
YoY Change	2.16%	1.45%
SHAREHOLDERS EQUITY
Retained Earnings	$650.1M	$380.0M
YoY Change	71.08%	124.45%
Common Stock	$3.215B	$3.306B
YoY Change	-2.76%	-9.42%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.487B	$4.227B
YoY Change
Total Liabilities & Shareholders Equity	$31.98B	$31.46B
YoY Change	1.65%	-0.43%

Cashflow Statement

Concept	2017 Q1	2016 Q1
OPERATING ACTIVITIES
Net Income	$62.30M	$45.50M
YoY Change	36.92%	-13.83%
Depreciation, Depletion And Amortization	$70.00M	$68.20M
YoY Change	2.64%	-3.94%
Cash From Operating Activities	$143.4M	$143.6M
YoY Change	-0.14%	17.22%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$8.900M	$3.800M
YoY Change	134.21%	-26.92%
Cash From Investing Activities	$107.0M	$155.0M
YoY Change	-30.97%	-144.75%
FINANCING ACTIVITIES
Cash Dividend Paid	$14.00M	$12.70M
YoY Change	10.24%	4.96%
Common Stock Issuance & Retirement, Net	$36.90M	$96.50M
YoY Change	-61.76%	13.53%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$33.90M	-$95.20M
YoY Change	-64.39%	-342.86%
NET CHANGE
Cash From Operating Activities	$143.4M	$143.6M
Cash From Investing Activities	$107.0M	$155.0M
Cash From Financing Activities	-$33.90M	-$95.20M
Net Change In Cash	$216.5M	$203.4M
YoY Change	6.44%	-210.12%
FREE CASH FLOW
Cash From Operating Activities	$143.4M	$143.6M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016Q4	cno	Accumulated Other Comprehensive Income Adjustment To Insurance Liabilities Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized AccumulatedOtherComprehensiveIncomeAdjustmentToInsuranceLiabilitiesDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	-13500000	USD
CY2017Q1	cno	Accumulated Other Comprehensive Income Adjustment To Insurance Liabilities Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized AccumulatedOtherComprehensiveIncomeAdjustmentToInsuranceLiabilitiesDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	-28800000	USD
CY2016Q4	cno	Accumulated Other Comprehensive Income Loss Adjustment To Deferred Policy Acquisition Costs AccumulatedOtherComprehensiveIncomeLossAdjustmentToDeferredPolicyAcquisitionCosts	-223500000	USD
CY2017Q1	cno	Accumulated Other Comprehensive Income Loss Adjustment To Deferred Policy Acquisition Costs AccumulatedOtherComprehensiveIncomeLossAdjustmentToDeferredPolicyAcquisitionCosts	-253700000	USD
CY2016Q4	cno	Accumulated Other Comprehensive Income Loss Adjustment To Present Value Of Future Profits AccumulatedOtherComprehensiveIncomeLossAdjustmentToPresentValueOfFutureProfits	-106200000	USD
CY2017Q1	cno	Accumulated Other Comprehensive Income Loss Adjustment To Present Value Of Future Profits AccumulatedOtherComprehensiveIncomeLossAdjustmentToPresentValueOfFutureProfits	-104900000	USD
CY2016Q4	cno	Accumulated Other Comprehensive Income Loss Deferred Income Tax Liabilities AccumulatedOtherComprehensiveIncomeLossDeferredIncomeTaxLiabilities	-345200000	USD
CY2017Q1	cno	Accumulated Other Comprehensive Income Loss Deferred Income Tax Liabilities AccumulatedOtherComprehensiveIncomeLossDeferredIncomeTaxLiabilities	-404500000	USD
CY2016Q4	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation Depreciation On Fixed Maturity Securities Available For Sale When Other Than Temporary Impairment Loss Was Recognized AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationDepreciationOnFixedMaturitySecuritiesAvailableForSaleWhenOtherThanTemporaryImpairmentLossWasRecognized	-1100000	USD
CY2017Q1	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation Depreciation On Fixed Maturity Securities Available For Sale When Other Than Temporary Impairment Loss Was Recognized AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationDepreciationOnFixedMaturitySecuritiesAvailableForSaleWhenOtherThanTemporaryImpairmentLossWasRecognized	800000	USD
CY2016Q4	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Gains Losses On All Other Investments AccumulatedOtherComprehensiveIncomeLossNetUnrealizedGainsLossesOnAllOtherInvestments	1311900000	USD
CY2017Q1	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Gains Losses On All Other Investments AccumulatedOtherComprehensiveIncomeLossNetUnrealizedGainsLossesOnAllOtherInvestments	1520700000	USD
CY2017Q1	cno	Aggregate Growth Rateforthe Next Five Years Includedin Deferred Tax Valuation Analysis AggregateGrowthRatefortheNextFiveYearsIncludedinDeferredTaxValuationAnalysis	0.03
CY2016Q1	cno	Amortization Related To Investment Gains Losses AmortizationRelatedToInvestmentGainsLosses	100000	USD
CY2017Q1	cno	Amortization Related To Investment Gains Losses AmortizationRelatedToInvestmentGainsLosses	0	USD
CY2017Q1	cno	Available For Sale Fixed Maturities With Significant Unobservable Inputs Investment Grade Percent AvailableForSaleFixedMaturitiesWithSignificantUnobservableInputsInvestmentGradePercent	0.52
CY2017Q1	cno	Available For Sale Maturities With Significant Unobservable Inputs Corporate Securities Percent AvailableForSaleMaturitiesWithSignificantUnobservableInputsCorporateSecuritiesPercent	0.75
CY2017Q1	cno	Available For Sale Securities Debt Maturities Amortized Cost Subtotal AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostSubtotal	14750600000	USD
CY2017Q1	cno	Available For Sale Securities Debt Maturities Fair Value Subtotal AvailableForSaleSecuritiesDebtMaturitiesFairValueSubtotal	16070500000	USD
CY2017Q1	cno	Available For Sale Securities Other Than Temporary Impairments Included In Accumulated Other Comprehensive Income Loss AvailableForSaleSecuritiesOtherThanTemporaryImpairmentsIncludedInAccumulatedOtherComprehensiveIncomeLoss	7900000	USD
CY2017Q1	cno	Available For Sale Securities Value Of Securities Sold AvailableForSaleSecuritiesValueOfSecuritiesSold	95300000	USD
CY2016Q1	cno	Benefits Losses And Expenses Excluding Amortization Related To Realized Gains Losses And Fair Value Changes In Embedded Derivative Liabilities Net Of Related Amortization And Income Taxes BenefitsLossesAndExpensesExcludingAmortizationRelatedToRealizedGainsLossesAndFairValueChangesInEmbeddedDerivativeLiabilitiesNetOfRelatedAmortizationAndIncomeTaxes	866400000	USD
CY2017Q1	cno	Benefits Losses And Expenses Excluding Amortization Related To Realized Gains Losses And Fair Value Changes In Embedded Derivative Liabilities Net Of Related Amortization And Income Taxes BenefitsLossesAndExpensesExcludingAmortizationRelatedToRealizedGainsLossesAndFairValueChangesInEmbeddedDerivativeLiabilitiesNetOfRelatedAmortizationAndIncomeTaxes	955700000	USD
CY2016Q4	cno	Borrowings Related To Variable Interest Entities BorrowingsRelatedToVariableInterestEntities	1662800000	USD
CY2017Q1	cno	Borrowings Related To Variable Interest Entities BorrowingsRelatedToVariableInterestEntities	1634200000	USD
CY2016Q4	cno	Cash And Cash Equivalents Held By Variable Interest Entities CashAndCashEquivalentsHeldByVariableInterestEntities	189300000	USD
CY2017Q1	cno	Cash And Cash Equivalents Held By Variable Interest Entities CashAndCashEquivalentsHeldByVariableInterestEntities	354500000	USD
CY2016Q1	cno	Change In Accrued Investment Income And Amortization Of Premium Or Discount On Investments ChangeInAccruedInvestmentIncomeAndAmortizationOfPremiumOrDiscountOnInvestments	-16900000	USD
CY2017Q1	cno	Change In Accrued Investment Income And Amortization Of Premium Or Discount On Investments ChangeInAccruedInvestmentIncomeAndAmortizationOfPremiumOrDiscountOnInvestments	-97500000	USD
CY2016Q1	cno	Change In Cash And Cash Equivalents Held By Variable Interest Entities ChangeInCashAndCashEquivalentsHeldByVariableInterestEntities	-174300000	USD
CY2017Q1	cno	Change In Cash And Cash Equivalents Held By Variable Interest Entities ChangeInCashAndCashEquivalentsHeldByVariableInterestEntities	165200000	USD
CY2016Q4	cno	Deferred Tax Assets Before Valuation Allowance DeferredTaxAssetsBeforeValuationAllowance	1025800000	USD
CY2017Q1	cno	Deferred Tax Assets Before Valuation Allowance DeferredTaxAssetsBeforeValuationAllowance	968800000	USD
CY2016Q1	cno	Embedded Derivative Amortization Related To Fair Value Changes In Embedded Derivative Liabilities EmbeddedDerivativeAmortizationRelatedToFairValueChangesInEmbeddedDerivativeLiabilities	-8500000	USD
CY2017Q1	cno	Embedded Derivative Amortization Related To Fair Value Changes In Embedded Derivative Liabilities EmbeddedDerivativeAmortizationRelatedToFairValueChangesInEmbeddedDerivativeLiabilities	-1100000	USD
CY2017Q1	cno	Estimated Normalized Annual Taxable Income For Current Year EstimatedNormalizedAnnualTaxableIncomeForCurrentYear	335000000	USD
CY2017Q1	cno	Estimated Normalized Annual Taxable Income For Current Year Life Income EstimatedNormalizedAnnualTaxableIncomeForCurrentYearLifeIncome	250000000	USD
CY2017Q1	cno	Estimated Normalized Annual Taxable Income For Current Year Nonlife Taxable Income EstimatedNormalizedAnnualTaxableIncomeForCurrentYearNonlifeTaxableIncome	85000000	USD
CY2016Q1	cno	Expenses Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests ExpensesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	12900000	USD
CY2017Q1	cno	Expenses Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests ExpensesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	13900000	USD
CY2016Q1	cno	Expensesrelatedtotransitionandsupportservicesagreements Expensesrelatedtotransitionandsupportservicesagreements	5000000	USD
CY2017Q1	cno	Expensesrelatedtotransitionandsupportservicesagreements Expensesrelatedtotransitionandsupportservicesagreements	0	USD
CY2016Q1	cno	Fair Value Compensation Plan Changesin Fair Value Gain Loss FairValueCompensationPlanChangesinFairValueGainLoss	-6000000	USD
CY2017Q1	cno	Fair Value Compensation Plan Changesin Fair Value Gain Loss FairValueCompensationPlanChangesinFairValueGainLoss	0	USD
CY2017Q1	cno	Fair Value Fixed Maturity Securities Valued Using Broker Quotes Percentage FairValueFixedMaturitySecuritiesValuedUsingBrokerQuotesPercentage	0.46
CY2017Q1	cno	Federal Long Term Tax Exempt Rate FederalLongTermTaxExemptRate	0.0209
CY2017Q1	cno	Future Cash Tax Payments As A Percent Of Life Insurance Taxable Income Due FutureCashTaxPaymentsAsAPercentOfLifeInsuranceTaxableIncomeDue	0.65
CY2016Q1	cno	Gain Losson Investments Excluding Cash Expenses GainLossonInvestmentsExcludingCashExpenses	-900000	USD
CY2017Q1	cno	Gain Losson Investments Excluding Cash Expenses GainLossonInvestmentsExcludingCashExpenses	7900000	USD
CY2016Q1	cno	Income Tax Expense Benefit Basedon Estimated Annual Effective Tax Rate IncomeTaxExpenseBenefitBasedonEstimatedAnnualEffectiveTaxRate	15000000	USD
CY2017Q1	cno	Income Tax Expense Benefit Basedon Estimated Annual Effective Tax Rate IncomeTaxExpenseBenefitBasedonEstimatedAnnualEffectiveTaxRate	34400000	USD
CY2016Q1	cno	Income Tax Expense Benefit Before Valuation Allowance Adjustment IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment	15000000	USD
CY2017Q1	cno	Income Tax Expense Benefit Before Valuation Allowance Adjustment IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment	34400000	USD
CY2016Q1	cno	Income Tax Expense Benefit Changein Valuation Allowanceon Discrete Items IncomeTaxExpenseBenefitChangeinValuationAllowanceonDiscreteItems	-20000000	USD
CY2017Q1	cno	Income Tax Expense Benefit Changein Valuation Allowanceon Discrete Items IncomeTaxExpenseBenefitChangeinValuationAllowanceonDiscreteItems	0	USD
CY2017Q1	cno	Increase To Deferred Tax Assets Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized IncreaseToDeferredTaxAssetsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	91000000	USD
CY2016Q1	cno	Insurance Policy Benefits InsurancePolicyBenefits	487400000	USD
CY2017Q1	cno	Insurance Policy Benefits InsurancePolicyBenefits	511800000	USD
CY2016Q4	cno	Investment Borrowings InvestmentBorrowings	1647400000	USD
CY2017Q1	cno	Investment Borrowings InvestmentBorrowings	1647200000	USD
CY2016Q4	cno	Investments Held By Variable Interest Entities InvestmentsHeldByVariableInterestEntities	1724300000	USD
CY2017Q1	cno	Investments Held By Variable Interest Entities InvestmentsHeldByVariableInterestEntities	1514500000	USD
CY2017Q1	cno	Investments Held In Limited Partnerships InvestmentsHeldInLimitedPartnerships	277600000	USD
CY2017Q1	cno	Loss Limitation Based On Income Of Life Insurance Company LossLimitationBasedOnIncomeOfLifeInsuranceCompany	0.35
CY2017Q1	cno	Loss Limitation Based On Loss Of Non Life Entities LossLimitationBasedOnLossOfNonLifeEntities	0.35
CY2016Q1	cno	Maturities And Redemptions Of Investments MaturitiesAndRedemptionsOfInvestments	349600000	USD
CY2017Q1	cno	Maturities And Redemptions Of Investments MaturitiesAndRedemptionsOfInvestments	849300000	USD
CY2016Q1	cno	Net Investment Income On General Account Invested Assets NetInvestmentIncomeOnGeneralAccountInvestedAssets	291000000	USD
CY2017Q1	cno	Net Investment Income On General Account Invested Assets NetInvestmentIncomeOnGeneralAccountInvestedAssets	312000000	USD
CY2016Q1	cno	Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios	11700000	USD
CY2017Q1	cno	Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios	75200000	USD
CY2016Q1	cno	Net Sales Purchases Of Trading Securities NetSalesPurchasesOfTradingSecurities	21700000	USD
CY2017Q1	cno	Net Sales Purchases Of Trading Securities NetSalesPurchasesOfTradingSecurities	-35600000	USD
CY2017Q1	cno	Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSale	1100000	USD
CY2017Q1	cno	Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale Tax NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSaleTax	600000	USD
CY2017Q1	cno	Number Of Insurance Subsidiaries That Are Members Of The Federal Home Loan Bank NumberOfInsuranceSubsidiariesThatAreMembersOfTheFederalHomeLoanBank	3	subsidiary
CY2017Q1	cno	Number Of Investments Held By Variable Interest Entities In Default NumberOfInvestmentsHeldByVariableInterestEntitiesInDefault	0	investment
CY2017Q1	cno	Number Of Product Distribution Channels NumberOfProductDistributionChannels	3	distribution_channel
CY2017Q1	cno	Number Of States Participating In Examination Of Compliance With Unclaimed Property Laws NumberOfStatesParticipatingInExaminationOfComplianceWithUnclaimedPropertyLaws	38	state
CY2016Q1	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax	45200000	USD
CY2017Q1	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax	-7800000	USD
CY2016Q1	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax	-168000000	USD
CY2017Q1	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax	-52000000	USD
CY2016Q1	cno	Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax	100000	USD
CY2017Q1	cno	Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax	0	USD
CY2016Q1	cno	Other Comprehensive Income Loss Unrealized Holding Gain Loss On Securities Arising During Period Net Of Reclassification And Amortization Adjustments Before Tax OtherComprehensiveIncomeLossUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfReclassificationAndAmortizationAdjustmentsBeforeTax	213100000	USD
CY2017Q1	cno	Other Comprehensive Income Loss Unrealized Holding Gain Loss On Securities Arising During Period Net Of Reclassification And Amortization Adjustments Before Tax OtherComprehensiveIncomeLossUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfReclassificationAndAmortizationAdjustmentsBeforeTax	166500000	USD
CY2017Q1	cno	Ownership Change Threshold Restricting Net Operating Loss Usage OwnershipChangeThresholdRestrictingNetOperatingLossUsage	0.5
CY2016Q4	cno	Persistency Bonus Benefits Included In Insurance Liabilities PersistencyBonusBenefitsIncludedInInsuranceLiabilities	500000	USD
CY2017Q1	cno	Persistency Bonus Benefits Included In Insurance Liabilities PersistencyBonusBenefitsIncludedInInsuranceLiabilities	500000	USD
CY2016Q1	cno	Policy Acquisition Costs PolicyAcquisitionCosts	62200000	USD
CY2017Q1	cno	Policy Acquisition Costs PolicyAcquisitionCosts	63200000	USD
CY2016Q4	cno	Prepaid Accrued Income Taxes Current PrepaidAccruedIncomeTaxesCurrent	4100000	USD
CY2017Q1	cno	Prepaid Accrued Income Taxes Current PrepaidAccruedIncomeTaxesCurrent	-15100000	USD
CY2016Q1	cno	Pretaxoperatingearnings Pretaxoperatingearnings	77600000	USD
CY2017Q1	cno	Pretaxoperatingearnings Pretaxoperatingearnings	92900000	USD
CY2016Q1	cno	Proceeds From Investment Borrowings Related To Variable Interest Entities ProceedsFromInvestmentBorrowingsRelatedToVariableInterestEntities	2900000	USD
CY2017Q1	cno	Proceeds From Investment Borrowings Related To Variable Interest Entities ProceedsFromInvestmentBorrowingsRelatedToVariableInterestEntities	8700000	USD
CY2016Q1	cno	Purchases Of Investments PurchasesOfInvestments	1524900000	USD
CY2017Q1	cno	Purchases Of Investments PurchasesOfInvestments	1166400000	USD
CY2017Q1	cno	Reduction To Deferred Acquisition Costs Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized ReductionToDeferredAcquisitionCostsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	134000000	USD
CY2017Q1	cno	Reduction To Present Value Of Future Profits Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized ReductionToPresentValueOfFutureProfitsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	93200000	USD
CY2016Q1	cno	Repayments Of Investment Borrowings Related To Variable Interest Entities RepaymentsOfInvestmentBorrowingsRelatedToVariableInterestEntities	23500000	USD
CY2017Q1	cno	Repayments Of Investment Borrowings Related To Variable Interest Entities RepaymentsOfInvestmentBorrowingsRelatedToVariableInterestEntities	38100000	USD
CY2016Q1	cno	Revenue Relatedto Transitionand Support Services Agreements RevenueRelatedtoTransitionandSupportServicesAgreements	5000000	USD
CY2017Q1	cno	Revenue Relatedto Transitionand Support Services Agreements RevenueRelatedtoTransitionandSupportServicesAgreements	0	USD
CY2016Q1	cno	Revenues Excluding Realized Gains Losses RevenuesExcludingRealizedGainsLosses	944000000	USD
CY2017Q1	cno	Revenues Excluding Realized Gains Losses RevenuesExcludingRealizedGainsLosses	1048600000	USD
CY2016Q1	cno	Revenues Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests RevenuesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	12300000	USD
CY2017Q1	cno	Revenues Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests RevenuesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	14200000	USD
CY2016Q1	cno	Sales Of Investments SalesOfInvestments	1181500000	USD
CY2017Q1	cno	Sales Of Investments SalesOfInvestments	403000000	USD
CY2016Q1	cno	Share Based Compensation Noncash Portion ShareBasedCompensationNoncashPortion	10200000	USD
CY2017Q1	cno	Share Based Compensation Noncash Portion ShareBasedCompensationNoncashPortion	6300000	USD
CY2016Q1	cno	Stock Based Compensation StockBasedCompensation	7500000	USD
CY2017Q1	cno	Stock Based Compensation StockBasedCompensation	7100000	USD
CY2017Q1	cno	Stock Repurchase Program Remaining Repurchase Authorized Amount StockRepurchaseProgramRemainingRepurchaseAuthorizedAmount	209700000	USD
CY2017Q1	cno	Unfunded Commitmentsto Limited Partnerships UnfundedCommitmentstoLimitedPartnerships	230500000	USD
CY2017Q1	cno	Valuation Allowance Deferred Tax Asset Valuation Model Forecast Periodof Model ValuationAllowanceDeferredTaxAssetValuationModelForecastPeriodofModel	P5Y
CY2016Q1	cno	Variable Interest Entities Investments Sold VariableInterestEntitiesInvestmentsSold	26200000	USD
CY2017Q1	cno	Variable Interest Entities Investments Sold VariableInterestEntitiesInvestmentsSold	20400000	USD
CY2016Q1	cno	Variable Interest Entities Net Realized Gain Loss On Investments VariableInterestEntitiesNetRealizedGainLossOnInvestments	-6400000	USD
CY2017Q1	cno	Variable Interest Entities Net Realized Gain Loss On Investments VariableInterestEntitiesNetRealizedGainLossOnInvestments	2100000	USD
CY2017Q1	cno	Variable Interest Entity Amortized Cost Securities Held VariableInterestEntityAmortizedCostSecuritiesHeld	1506100000	USD
CY2017Q1	cno	Variable Interest Entity Fixed Maturity Securities Fair Value VariableInterestEntityFixedMaturitySecuritiesFairValue	1514500000	USD
CY2017Q1	cno	Variable Interest Entity Gross Unrealized Gains Fixed Maturity Securities VariableInterestEntityGrossUnrealizedGainsFixedMaturitySecurities	12600000	USD
CY2017Q1	cno	Variable Interest Entity Gross Unrealized Losses Fixed Maturity Securities VariableInterestEntityGrossUnrealizedLossesFixedMaturitySecurities	4200000	USD
CY2016Q1	cno	Variable Interest Entity Investments Gross Investment Losses From Sale Before Tax VariableInterestEntityInvestmentsGrossInvestmentLossesFromSaleBeforeTax	6500000	USD
CY2017Q1	cno	Variable Interest Entity Investments Gross Investment Losses From Sale Before Tax VariableInterestEntityInvestmentsGrossInvestmentLossesFromSaleBeforeTax	100000	USD
CY2017Q1	dei	Amendment Flag AmendmentFlag	false
CY2017Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2017Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2017Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017Q1	dei	Document Period End Date DocumentPeriodEndDate	2017-03-31
CY2017Q1	dei	Document Type DocumentType	10-Q
CY2017Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001224608
CY2017Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	171311512	shares
CY2017Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2017Q1	dei	Entity Registrant Name EntityRegistrantName	CNO Financial Group, Inc.
CY2016Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	239600000	USD
CY2017Q1	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	258200000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	622400000	USD
CY2017Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	729600000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	3212100000	USD
CY2017Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	3177100000	USD
CY2017Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	3213000000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	203400000	USD
CY2016Q1	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	62100000	USD
CY2017Q1	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	63500000	USD
CY2016Q4	us-gaap	Assets Assets	31975200000	USD
CY2017Q1	us-gaap	Assets Assets	32427400000	USD
CY2017Q1	us-gaap	Assets Assets	31975500000	USD
CY2016Q1	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	8800000	USD
CY2017Q1	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	8000000	USD
CY2016Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	19803100000	USD
CY2017Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	19880300000	USD
CY2016Q4	us-gaap	Available For Sale Equity Securities Amortized Cost Basis AvailableForSaleEquitySecuritiesAmortizedCostBasis	580700000	USD
CY2017Q1	us-gaap	Available For Sale Equity Securities Amortized Cost Basis AvailableForSaleEquitySecuritiesAmortizedCostBasis	571300000	USD
CY2016Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	84800000	USD
CY2017Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	66500000	USD
CY2016Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	194300000	USD
CY2017Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	134200000	USD
CY2016Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	4500600000	USD
CY2017Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	3561500000	USD
CY2016Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	109500000	USD
CY2017Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	67700000	USD
CY2016Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	3440800000	USD
CY2017Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	2667400000	USD
CY2016Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	1059800000	USD
CY2017Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	894100000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	1539000000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	1625600000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	2242900000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	2400700000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	10636600000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	11706700000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	332100000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	337500000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost	5129700000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	5307900000	USD
CY2016Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	21096200000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	21378400000	USD
CY2016Q4	us-gaap	Available For Sale Securities Equity Securities AvailableForSaleSecuritiesEquitySecurities	584200000	USD
CY2017Q1	us-gaap	Available For Sale Securities Equity Securities AvailableForSaleSecuritiesEquitySecurities	587800000	USD
CY2016Q1	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	919900000	USD
CY2017Q1	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	974000000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	432300000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	635700000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	478900000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	530200000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	51300000	USD
CY2016Q1	us-gaap	Ceded Premiums Written CededPremiumsWritten	33600000	USD
CY2017Q1	us-gaap	Ceded Premiums Written CededPremiumsWritten	26300000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.08
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	8000000000	shares
CY2017Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	8000000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	173753614	shares
CY2017Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	172103802	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	173753614	shares
CY2017Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	172103802	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	1700000	USD
CY2017Q1	us-gaap	Common Stock Value CommonStockValue	1700000	USD
CY2016Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	183200000	USD
CY2017Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	169500000	USD
CY2016Q4	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	300000	USD
CY2016Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	4100000	USD
CY2017Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	20600000	USD
CY2016Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	912900000	USD
CY2017Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	913400000	USD
CY2016Q4	us-gaap	Deferred Finance Costs Noncurrent Gross DeferredFinanceCostsNoncurrentGross	12100000	USD
CY2017Q1	us-gaap	Deferred Finance Costs Noncurrent Gross DeferredFinanceCostsNoncurrentGross	11600000	USD
CY2016Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	789700000	USD
CY2017Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	697800000	USD
CY2017Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	790000000	USD
CY2016Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	10900000	USD
CY2017Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	13800000	USD
CY2016Q1	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-20000000	USD
CY2017Q1	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	0	USD
CY2016Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	1044700000	USD
CY2017Q1	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	1028500000	USD
CY2016Q1	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	1000000	USD
CY2017Q1	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	500000	USD
CY2016Q1	us-gaap	Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense	1700000	USD
CY2017Q1	us-gaap	Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense	2100000	USD
CY2016Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	49400000	USD
CY2017Q1	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	47800000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1647700000	USD
CY2017Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1648600000	USD
CY2017Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1045900000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	17800000	USD
CY2016Q1	us-gaap	Fees And Commissions FeesAndCommissions	14200000	USD
CY2017Q1	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	15900000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	789700000	USD
CY2017Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	697800000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	785600000	USD
CY2017Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	712900000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	882900000	USD
CY2017Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	884500000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	12300000	USD
CY2017Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	12200000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	65600000	USD
CY2017Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	59900000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards General Business DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness	700000	USD
CY2017Q1	us-gaap	Deferred Tax Assets Tax Credit Carryforwards General Business DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness	300000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Policyholder Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsPolicyholderLiabilities	668400000	USD
CY2017Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Policyholder Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsPolicyholderLiabilities	675800000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	240200000	USD
CY2017Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	255900000	USD
CY2017Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	255900000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	621900000	USD
CY2017Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	679800000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost	277800000	USD
CY2017Q1	us-gaap	Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost	275900000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Other Comprehensive Income DeferredTaxLiabilitiesOtherComprehensiveIncome	344100000	USD
CY2017Q1	us-gaap	Deferred Tax Liabilities Other Comprehensive Income DeferredTaxLiabilitiesOtherComprehensiveIncome	403900000	USD
CY2016Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	68200000	USD
CY2017Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	70000000	USD
CY2016Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-43100000	USD
CY2017Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	47500000	USD
CY2016Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	12600000	USD
CY2017Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	14000000	USD
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.25
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.36
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.25
CY2017Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.36
CY2016Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.370	Rate
CY2017Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.356	Rate
CY2016Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35	Rate
CY2017Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35	Rate
CY2016Q1	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.008	Rate
CY2017Q1	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.011	Rate
CY2016Q1	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.012	Rate
CY2017Q1	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.017	Rate
CY2016Q1	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	-38000000	USD
CY2017Q1	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	-5500000	USD
CY2017Q1	us-gaap	Fees And Commissions FeesAndCommissions	11800000	USD
CY2016Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-900000	USD
CY2017Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	7900000	USD
CY2016Q1	us-gaap	Gain Loss On Investments Excluding Other Than Temporary Impairments GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments	9100000	USD
CY2017Q1	us-gaap	Gain Loss On Investments Excluding Other Than Temporary Impairments GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments	16300000	USD
CY2016Q1	us-gaap	Impairment Of Investments ImpairmentOfInvestments	10000000	USD
CY2017Q1	us-gaap	Impairment Of Investments ImpairmentOfInvestments	8400000	USD
CY2016Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	40500000	USD
CY2017Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	96700000	USD
CY2016Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5000000	USD
CY2017Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	34400000	USD
CY2016Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	1100000	USD
CY2017Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	1500000	USD
CY2016Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-6100000	USD
CY2017Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	32900000	USD
CY2016Q1	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	62200000	USD
CY2017Q1	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	63200000	USD
CY2016Q1	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	103700000	USD
CY2017Q1	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	131600000	USD
CY2016Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1778000	shares
CY2017Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1634000	shares
CY2016Q1	us-gaap	Interest Expense InterestExpense	27700000	USD
CY2017Q1	us-gaap	Interest Expense InterestExpense	30800000	USD
CY2016Q1	us-gaap	Interest Paid InterestPaid	13300000	USD
CY2017Q1	us-gaap	Interest Paid InterestPaid	20500000	USD
CY2016Q4	us-gaap	Investments Investments	26237600000	USD
CY2017Q1	us-gaap	Investments Investments	26387900000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	27488300000	USD
CY2017Q1	us-gaap	Liabilities Liabilities	27820600000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31975200000	USD
CY2017Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32427400000	USD
CY2017Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31975500000	USD
CY2016Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	500600000	USD
CY2017Q1	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	498100000	USD
CY2016Q4	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	10953300000	USD
CY2017Q1	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	11057200000	USD
CY2017Q1	us-gaap	Long Term Debt LongTermDebt	925000000	USD
CY2017Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	500000000	USD
CY2017Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	USD
CY2017Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	0	USD
CY2017Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	325000000	USD
CY2017Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	100000000	USD
CY2017Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	USD
CY2016Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	1768000000	USD
CY2017Q1	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	1788500000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-95200000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-33900000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	155000000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-55800000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	143600000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	141000000	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	45500000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	62300000	USD
CY2016Q4	us-gaap	Notes Payable NotesPayable	912900000	USD
CY2017Q1	us-gaap	Notes Payable NotesPayable	913400000	USD
CY2017Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	2527000000	USD
CY2016Q4	us-gaap	Other Assets OtherAssets	328500000	USD
CY2017Q1	us-gaap	Other Assets OtherAssets	535800000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	213700000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	166500000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	137700000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	107200000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax	-600000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax	0	USD
CY2016Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	4900000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	5100000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	76000000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	59300000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	431100000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	215800000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	137700000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	106100000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	76000000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	58700000	USD
CY2016Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	211100000	USD
CY2017Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	210400000	USD
CY2016Q4	us-gaap	Other Investments OtherInvestments	589500000	USD
CY2017Q1	us-gaap	Other Investments OtherInvestments	665200000	USD
CY2016Q4	us-gaap	Other Liabilities OtherLiabilities	611400000	USD
CY2017Q1	us-gaap	Other Liabilities OtherLiabilities	798000000	USD
CY2016Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	10500000	USD
CY2017Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	12800000	USD
CY2016Q1	us-gaap	Payments For Other Operating Activities PaymentsForOtherOperatingActivities	209700000	USD
CY2017Q1	us-gaap	Payments For Other Operating Activities PaymentsForOtherOperatingActivities	203600000	USD
CY2016Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	3800000	USD
CY2017Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	12100000	USD
CY2017Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	43000000	USD
CY2016Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	96900000	USD
CY2017Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	39800000	USD
CY2016Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	12700000	USD
CY2017Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	14000000	USD
CY2016Q4	us-gaap	Policy Loans Receivable PolicyLoansReceivable	112000000	USD
CY2017Q1	us-gaap	Policy Loans Receivable PolicyLoansReceivable	112400000	USD
CY2016Q1	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	619000000	USD
CY2017Q1	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	669300000	USD
CY2016Q4	us-gaap	Policyholder Funds PolicyholderFunds	10912700000	USD
CY2017Q1	us-gaap	Policyholder Funds PolicyholderFunds	10975100000	USD
CY2016Q1	us-gaap	Premiums Earned Net PremiumsEarnedNet	644400000	USD
CY2017Q1	us-gaap	Premiums Earned Net PremiumsEarnedNet	663800000	USD
CY2016Q1	us-gaap	Proceeds From Annuities And Investment Certificates ProceedsFromAnnuitiesAndInvestmentCertificates	340100000	USD
CY2017Q1	us-gaap	Proceeds From Annuities And Investment Certificates ProceedsFromAnnuitiesAndInvestmentCertificates	359500000	USD
CY2016Q1	us-gaap	Proceeds From Fees Received ProceedsFromFeesReceived	14200000	USD
CY2017Q1	us-gaap	Proceeds From Fees Received ProceedsFromFeesReceived	11800000	USD
CY2016Q1	us-gaap	Proceeds From Insurance Premiums Collected ProceedsFromInsurancePremiumsCollected	617300000	USD
CY2017Q1	us-gaap	Proceeds From Insurance Premiums Collected ProceedsFromInsurancePremiumsCollected	640100000	USD
CY2016Q1	us-gaap	Proceeds From Interest And Dividends Received ProceedsFromInterestAndDividendsReceived	285800000	USD
CY2017Q1	us-gaap	Proceeds From Interest And Dividends Received ProceedsFromInterestAndDividendsReceived	289700000	USD
CY2016Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	400000	USD
CY2017Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2900000	USD
CY2016Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-900000	USD
CY2017Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	7900000	USD
CY2016Q1	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	40400000	USD
CY2017Q1	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	24100000	USD
CY2016Q4	us-gaap	Reinsurance Recoverables On Paid Losses ReinsuranceRecoverablesOnPaidLosses	2260400000	USD
CY2017Q1	us-gaap	Reinsurance Recoverables On Paid Losses ReinsuranceRecoverablesOnPaidLosses	2241100000	USD
CY2016Q1	us-gaap	Repayments Of Annuities And Investment Certificates RepaymentsOfAnnuitiesAndInvestmentCertificates	305300000	USD
CY2017Q1	us-gaap	Repayments Of Annuities And Investment Certificates RepaymentsOfAnnuitiesAndInvestmentCertificates	312900000	USD
CY2016Q1	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	200000	USD
CY2017Q1	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	200000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	650700000	USD
CY2017Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	698400000	USD
CY2017Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	650100000	USD
CY2016Q1	us-gaap	Revenues Revenues	960400000	USD
CY2017Q1	us-gaap	Revenues Revenues	1070700000	USD
CY2016Q4	us-gaap	Separate Account Assets SeparateAccountAssets	4700000	USD
CY2017Q1	us-gaap	Separate Account Assets SeparateAccountAssets	4600000	USD
CY2016Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	4700000	USD
CY2017Q1	us-gaap	Separate Accounts Liability SeparateAccountsLiability	4600000	USD
CY2017Q1	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	62000	shares
CY2016Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	90000000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	4138500000	USD
CY2016Q1	us-gaap	Stockholders Equity StockholdersEquity	4226600000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	4486900000	USD
CY2017Q1	us-gaap	Stockholders Equity StockholdersEquity	4606800000	USD
CY2017Q1	us-gaap	Stockholders Equity StockholdersEquity	4487200000	USD
CY2016Q4	us-gaap	Trading Securities TradingSecurities	363400000	USD
CY2017Q1	us-gaap	Trading Securities TradingSecurities	341100000	USD
CY2016Q4	us-gaap	Unearned Premiums UnearnedPremiums	282500000	USD
CY2017Q1	us-gaap	Unearned Premiums UnearnedPremiums	292800000	USD
CY2016Q4	us-gaap	Value Of Business Acquired Voba ValueOfBusinessAcquiredVOBA	401800000	USD
CY2017Q1	us-gaap	Value Of Business Acquired Voba ValueOfBusinessAcquiredVOBA	388800000	USD
CY2016Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	182128000	shares
CY2017Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	175065000	shares
CY2016Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	180350000	shares
CY2017Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	173431000	shares
CY2017Q1	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">LITIGATION AND OTHER LEGAL PROCEEDINGS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Legal Proceedings</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company and its subsidiaries are involved in various legal actions in the normal course of business, in which claims for compensatory and punitive damages are asserted, some for substantial amounts.  We recognize an estimated loss from these loss contingencies when we believe it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Some of the pending matters have been filed as purported class actions and some actions have been filed in certain jurisdictions that permit punitive damage awards that are disproportionate to the actual damages incurred.  The amounts sought in certain of these actions are often large or indeterminate and the ultimate outcome of certain actions is difficult to predict.  In the event of an adverse outcome in one or more of these matters, there is a possibility that the ultimate liability may be in excess of the liabilities we have established and could have a material adverse effect on our business, financial condition, results of operations and cash flows.  In addition, the resolution of pending or future litigation may involve modifications to the terms of outstanding insurance policies or could impact the timing and amount of rate increases, which could adversely affect the future profitability of the related insurance policies.  Based upon information presently available, and in light of legal, factual and other defenses available to the Company and its subsidiaries, the Company does not believe that it is probable that the ultimate liability from either pending or threatened legal actions, after consideration of existing loss provisions, will have a material adverse effect on the Company's consolidated financial condition, operating results or cash flows. However, given the inherent difficulty in predicting the outcome of legal proceedings, there exists the possibility that such legal actions could have a material adverse effect on the Company's consolidated financial condition, operating results or cash flows.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition to the inherent difficulty of predicting litigation outcomes, particularly those that will be decided by a jury, some matters purport to seek substantial or an unspecified amount of damages for unsubstantiated conduct spanning several years based on complex legal theories and damages models. The alleged damages typically are indeterminate or not factually supported in the complaint, and, in any event, the Company's experience indicates that monetary demands for damages often bear little relation to the ultimate loss. In some cases, plaintiffs are seeking to certify classes in the litigation and class certification either has been denied or is pending and we have filed oppositions to class certification or sought to decertify a prior class certification. In addition, for many of these cases: (i) there is uncertainty as to the outcome of pending appeals or motions; (ii) there are significant factual issues to be resolved; and/or (iii) there are novel legal issues presented. Accordingly, the Company cannot reasonably estimate the possible loss or range of loss in excess of amounts accrued, if any, or predict the timing of the eventual resolution of these matters.  The Company reviews these matters on an ongoing basis.  When assessing reasonably possible and probable outcomes, the Company bases its assessment on the expected ultimate outcome following all appeals.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On September 29, 2016, Washington National and Bankers Conseco Life Insurance Company ("BCLIC") commenced an arbitration proceeding seeking compensatory, consequential and punitive damages against BRe based upon BRe’s incurable material breaches of the long-term care reinsurance agreements, conversion, fraud, and breaches of fiduciary duties and the obligation to deal honestly and in good faith. BRe filed a counterclaim against Washington National and BCLIC in the arbitration alleging damages relating to the reinsurance agreements and their termination. In addition, on September 29, 2016, a complaint was filed by BCLIC and Washington National in the United States District Court for the Southern District of New York, Bankers Conseco Life Insurance Company and Washington National Insurance Company v. Moshe M. Feuer, Scott Taylor and David Levy, Case No. 16-cv-7646, alleging, among other claims, fraud/fraudulent concealment, and violation of the Racketeer Influenced and Corrupt Organizations Act. These allegations relate to the long-term care reinsurance agreements between BRe and Washington National and BCLIC, respectively, and emanate from the undisclosed relationships between and among the defendants (who were the principal owners and officers of BRe) and Platinum Partners, LP ("Platinum") and its affiliates. On April 27, 2017, an amended complaint was filed adding Beechwood Capital Group, LLC as a defendant. Washington National and BCLIC intend to vigorously pursue their claims for damages and other remedies in the arbitration and the litigation described above.</font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On July 20, 2007, a complaint was filed in the Hamilton County, Indiana Circuit Court, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Signature Estates of Indiana, Inc. d/b/a Gordon Marketing, Stephens-Matthews Marketing, Inc., Shields Brokerage, Inc. and Edwin A Hildebrand d/b/a Hildebrand Insurance Services v. Conseco Medical Insurance Company, Conseco Medical Insurance Company a/k/a Washington National Insurance Company and Washington National Insurance Company, Cause No. 29D02- 0707-PL-790.  </font><font style="font-family:inherit;font-size:10pt;">The Plaintiffs are independent insurance marketing organizations which previously marketed Conseco Medical Insurance Company ("CMIC") individual major medical products and which are claiming damages for allegedly fraudulent conduct by CMIC in withdrawing from this business in 2002.  The Plaintiffs contend that they relied on CMIC’s alleged representations that its major medical business was profitable and that CMIC was committed to it.  The Plaintiffs further allege that when CMIC exited the market, it caused agents that were previously writing business through their organizations to cease doing business with them, thereby causing irreparable damage.  CMIC merged into Washington National, effective July 1, 2003.  On December 16, 2016, following a jury trial, verdicts were entered in favor of the plaintiffs, and compensatory damages aggregating </font><font style="font-family:inherit;font-size:10pt;">$4.7 million</font><font style="font-family:inherit;font-size:10pt;"> and punitive damages aggregating </font><font style="font-family:inherit;font-size:10pt;">$6.0 million</font><font style="font-family:inherit;font-size:10pt;"> were awarded to the plaintiffs.  Washington National has filed post-trial motions requesting the court correct errors, grant a new trial, find that punitive damages were improper, and reduce both compensatory and punitive damages.  Plaintiffs filed motions requesting pre-judgment interest and attorney fees.  A hearing on the post-trial motions is set for May 30, 2017. We believe the case is without merit and intend to defend it vigorously.</font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Regulatory Examinations and Fines</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Insurance companies face significant risks related to regulatory investigations and actions.  Regulatory investigations generally result from matters related to sales or underwriting practices, payment of contingent or other sales commissions, claim payments and procedures, product design, product disclosure, additional premium charges for premiums paid on a periodic basis, denial or delay of benefits, charging excessive or impermissible fees on products, procedures related to canceling policies, changing the way cost of insurance charges are calculated for certain life insurance products or recommending unsuitable products to customers.  We are, in the ordinary course of our business, subject to various examinations, inquiries and information requests from state, federal and other authorities.  The ultimate outcome of these regulatory actions (including the costs of complying with information requests and policy reviews) cannot be predicted with certainty.  In the event of an unfavorable outcome in one or more of these matters, the ultimate liability may be in excess of liabilities we have established and we could suffer significant reputational harm as a result of these matters, which could also have a material adverse effect on our business, financial condition, results of operations or cash flows.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2011, we were notified of an examination to be done on behalf of a number of states for the purpose of determining compliance with unclaimed property laws by the Company and its subsidiaries.  Such examination has included inquiries related to the use of data available on the U.S. Social Security Administration's Death Master File to identify instances where benefits under life insurance policies, annuities and retained asset accounts are payable. We are continuing to provide information to the examiners in response to their requests. A total of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">38</font><font style="font-family:inherit;font-size:10pt;"> states and the District of Columbia are currently participating in this examination.</font></div></div>

Files In Submission

Name	View Source	Status
0001224608-17-000024-index-headers.html	Edgar Link	pending
0001224608-17-000024-index.html	Edgar Link	pending
0001224608-17-000024.txt	Edgar Link	pending
0001224608-17-000024-xbrl.zip	Edgar Link	pending
cno-20170331.xml	Edgar Link	completed
cno-20170331.xsd	Edgar Link	pending
cno-20170331_cal.xml	Edgar Link	unprocessable
cno-20170331_def.xml	Edgar Link	unprocessable
cno-20170331_lab.xml	Edgar Link	unprocessable
cno-20170331_pre.xml	Edgar Link	unprocessable
cno0331201710-q.htm	Edgar Link	pending
cno03312017ex101.htm	Edgar Link	pending
cno03312017ex102.htm	Edgar Link	pending
cno03312017ex103.htm	Edgar Link	pending
cno03312017ex121.htm	Edgar Link	pending
cno03312017ex311.htm	Edgar Link	pending
cno03312017ex312.htm	Edgar Link	pending
cno03312017ex321.htm	Edgar Link	pending
cno03312017ex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
orgchartclic.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CNO
CNO Financial Group, Inc. Stock $cno

2017 Q1 Form 10-Q Financial Statement

#000122460817000024 Filed on May 03, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CNO CNO Financial Group, Inc. Stock $cno

2017 Q1 Form 10-Q Financial Statement

#000122460817000024 Filed on May 03, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CNO
CNO Financial Group, Inc. Stock $cno